ロード中...
Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer
INTRODUCTION: Apalutamide and enzalutamide are next-generation androgen receptor inhibitors that demonstrated efficacy in placebo-controlled studies (SPARTAN for apalutamide; PROSPER for enzalutamide) when used in combination with androgen deprivation therapy (ADT) for treatment of non-metastatic ca...
保存先:
| 出版年: | Adv Ther |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6979453/ https://ncbi.nlm.nih.gov/pubmed/31813086 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-019-01156-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|